Transfusion and Long-term Hemodialysis

Archives of Internal Medicine

Volumn 147, Issue 11, 1987, Pages 1925-1928

  Crowley, James P ^a,b   Nealey, Tara A ^a   Metzger, Jaclyn ^b   Pono, Lucille ^b   Chazan, Joseph A ^a,b  

^a BROWN UNIVERSITY   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD TRANSFUSION; CHRONIC KIDNEY FAILURE; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY;

BLOOD TRANSFUSION; COMPARATIVE STUDY; FEMALE; HEMODIALYSIS UNITS, HOSPITAL; HUMAN; KIDNEY FAILURE, CHRONIC; MALE; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RHODE ISLAND; SUPPORT, U.S. GOV'T, P.H.S.; TIME FACTORS;

EID: 0023489234     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.1987.00370110053008     Document Type: Article

References (21)

1. Data Committee of the National Forum of End-Stage Renal Disease Networks: Using end-stage renal disease facility surveys to monitor end-stage renal disease program trends. JAMA 1985;254:1776-1780.
2. Anagnostou A, Kurtzman NA: The anemia of chronic renal failure. Semin Nephrol 1985;5:115-127.
3. Linton AL, Clark WF, Driedger AA, et al: Correctable factors contributing to the anemia of dialysis patients. Nephrology 1977;19:95-98.
4. Goldberg AP, Hagberg J, Delmez JA, et al: The metabolic and psychological effects of exercise training in hemodialysis patients. Am J Clin Nutr 1980;33:1620-1628.
5. Halliday JW, Powell LW: Iron overload. Semin Hematol 1982;19:42-53.
6. Berkman SA: Infectious complications of blood transfusions. Semin Oncol 1984;11:68-76.
7. Peterman TA, Lang GR, Mikos NJ, et al: HTLV-III/LAV infection in hemodialysis patients. JAMA 1986;255:2324-2326.
8. Eschbach JW, Egrie JC, Downing MR, et al: Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. N Engl J Med 1987;316:73-78.
9. Yankee RA, Moser CP: AIDS and the blood supply. RI Med J 1987;70:11-17.
10. Schuett H, Port FK: Hemolysis in hemodialysis patients. Dial Transplant 1980;9:345-347.
11. Eschbach JW, Funk D, Adamson J, et al: Erythropoiesis in patients with renal failure undergoing chronic dialysis. N Engl J Med 1967;276: 653-685.
12. Miller ME, Zaroulis CG, Valeri CR, et al: Oxygen transport by the red cell: Effects of chronic hemodialysis. Blood 1974;43:49-56.
13. Lichtman MA, Miller DR: Erythrocyte glycolysis, 2,3-diphosphoglycerate and adenosine triphosphate concentration in uremic subjects: Relationship to extracellular phosphate concentration. J Lab Clin Med 1970;76:267-279.
14. Lichtman MA, Murphy MS, Byer BJ, et al: Hemoglobin affinity for oxygen in chronic renal disease: The effect of hemodialysis. Blood 1974;43: 417-424.
15. Hellerstedt WL, Johnson WJ, Ascher N, et al: Survival rates of 2728 patients with end-stage renal disease. Mayo Clin Proc 1984;59:776-783.
16. Friedman BA, Burns TL, Schork MA: A study of blood utilization by diagnosis, month of transfusion, and geographic region of the United States. Transfusion 1979;19:511-525.
17. Friedman BA, Burns TL, Schork MA: An analysis of blood transfusion of surgical patients by sex: A quest for the transfusion trigger. Transfusion 1980;20:179-188.
18. Williams JS, Stein JH, Ferris TF: Nandrolone deconoate therapy for patients receiving hemodialysis. Arch Intern Med 1974;134:289-292.
19. Dainiak N: The role of androgens in the treatment of anemia of chronic renal failure. Semin Nephrol 1985;5:147-154.
20. Shahidi NT: Androgens and erythropoiesis. N Engl J Med 1973;289: 72-80.
21. Schafer AI, Cheron RG, Dluhy R, et al: Clinical consequences of acquired transfusional iron overload in adults. N Engl J Med 1981;304: 319-324.